Page 4 - PULSE- JULY -2020

Kit and (iv) Rapid antibody test lateral flow kit
have been approved and is ready for marketing.
The Rapid antigen lateral flow kit, antibody ELISA
kit and RT-PCR kit is awaiting final DCGI approval.

RGCB worked to knock down
the lockdown!

Over the last few weeks we have all been
overpowered with what is happening all around
the world on Covid-19. The world has changed
ever since Covid-19 started unleashing its lethal
power. The way we live, work, eat, socialize, etc.
have changed and have given new dimension
to our life. Our hearts go out to everyone who
has been impacted by the virus either directly or
indirectly. We also salute those at the front line,
medical staff and care givers who put themselves
at risk to do all it takes to serve others.

In much the same way, we at RGCB are doing
our bit to fight against this deadly virus using
our expertise and knowledge gained over the
past three decades to offer solutions and keep
everyone safe. Towards this, I want to share some
of the things done by my very enterprising team at
RGCB, over the past few weeks when the country
and RGCB were locked down

Developments & Discoveries

RGCB fulfilled its promise to the Two national collaborations - Nano based
Honorable Union Minister for Health and Science anti-viral surface coatings for facemasks & PPE
& Technology that it would deliver a complete and use of deep learning for development of
COVID 19 Diagnostic suite. Accordingly along with continuous flow type ddPCR.
RGCB’s commercial partner POCT Services, New
Delhi, the Q LINE series of diagnostic reagents RGCB Director was nominated as member
were co-developed. These include (i) Low cost of the PM CARES - COVID 19 Vaccine Expert
Viral Transport Medium, (ii) Viral RNA Extraction Group.